Proton-pump inhibitors (PPIs) are the most effective therapy for the full spectrum of gastric-
acid-related diseases. However, in the past decade, a steadily increasing list of …

Proton pump inhibitors (PPIs) have been increasingly used over the last decades and there
are concerns about overuse and the numerous reported side-effects. It is uncertain whether …

The association between proton pump inhibitors (PPI) use and risk of acute interstitial
nephritis has been described. However, whether exposure to PPI associates with incident …

Objective Proton pump inhibitors (PPIs) are widely used, and their use is associated with
increased risk of adverse events. However, whether PPI use is associated with excess risk of …

Proton pump inhibitors (PPIs) reliably suppress gastric acid secretion and are therefore the
first‐line treatment for gastric acid‐related disorders. Hypomagnesemia (serum magnesium …

Background: The reported risk of hypomagnesemia in patients with proton pump inhibitor
(PPI) use is conflicting. The objective of this meta-analysis was to assess the association …

Background: Previous meta-analyses have suggested that there might be an association
between the use of proton pump inhibitors (PPIs) and the development of hypomagnesemia …

Proton pump inhibitors (PPIs), long thought to be safe, are associated with a number of
nonkidney adverse health outcomes and several untoward kidney outcomes, including …

Background Although many case reports have described patients with proton pump inhibitor
(PPI)-induced hypomagnesemia, the impact of PPI use on hypomagnesemia has not been …

Background Proton pump inhibitor (PPI) use has been associated with hypomagnesemia in
case reports and hospital-based cohort studies. Our objective was to determine whether PPI …